The effect of a low-dose naloxone infusion on the incidence of respiratory depression after intrathecal morphine administration for major open hepatobiliary surgery: A randomised controlled trial
Anaesthesia Jan 14, 2020
Cosgrave D, Vencken S, Galligan M, et al. - Among patients listed for major open hepatopancreaticobiliary surgery and who were receiving 10 μg.kg−1 intrathecal morphine, researchers undertook this analysis to investigate if a reduced incidence of respiratory depression without an increase in pain scores could be achieved with a postoperative low-dose naloxone infusion, given intrathecal morphine is related to a risk of respiratory depression. The participants were randomly assigned to receive a postoperative infusion of naloxone 5 μg.kg−1.h−1 (naloxone group) or saline at an identical infusion rate (control group) until the morning post-surgery. According to the findings, a reduced incidence of respiratory depression after intrathecal morphine treatment was brought about by a low-dose naloxone infusion in patients undergoing major hepatopancreaticobiliary surgery at the expense of a small rise in postoperative pain.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries